Company news

Immunitybio, Inc. (NASDAQ:IBRX) news

Immunitybio, Inc. news releases on 6ix. Latest, Nov 7, 2019: NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy…

View Immunitybio, Inc. →

Press releases — page 5

NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell Carcinoma at SITC 2019

November 6, 2019

← Newer